DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (QoQ) (2019 - 2026)
DiaMedica Therapeutics (DMAC) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130,883.57% |
| Dec 31, 2025 | 18.26% |
| Sep 30, 2025 | 79.97% |
| Jun 30, 2025 | 99.97% |
| Mar 31, 2025 | -990,742.05% |
| Dec 31, 2024 | 41.79% |
| Sep 30, 2024 | 74.03% |
| Jun 30, 2024 | 98.20% |
| Mar 31, 2024 | -4,198.83% |
| Dec 31, 2023 | 37.03% |
| Sep 30, 2023 | -776.55% |
| Jun 30, 2023 | 97.32% |
| Mar 31, 2023 | -896.70% |
| Dec 31, 2022 | 81.83% |
| Mar 31, 2022 | -1,751.88% |
| Dec 31, 2021 | -1,308.58% |
| Sep 30, 2021 | 68.18% |
| Jun 30, 2021 | -6,478.15% |
| Mar 31, 2021 | -7.85% |
| Dec 31, 2020 | 94.56% |